Wednesday, May 8, 2013

Gene fusion reduces NSCLC patient survival

ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest.

via Med Wire News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)